近年来，上海农商银行坚持"谋科创就是谋未来"理念，着力深耕金融资源最稀缺、服务难度最大的"0-1 阶段"成果转化项目及初创期科技企业服务，布局从"孵化"到"成熟"的接力培育体系。 未来，上海农商银行将聚焦"捐赠 +"项目全生命周期需求深化合作，提供覆盖公司成立前后的金融服务 与孵化赋能，配套人才服务等增值支持，同时激活专家库资源，推动更多科研成果落地转化，共同为上 海科创产业高质量发展注入动力。 银行频道更多独家策划、专家专栏，免费查阅>> 责任编辑：小讯 1月28日，上海农商银行创新推出的、旨在推动早期科研转化的"捐赠+"模式首期10个项目落地，上海农 商银行副行长张跃红、上海理工大学副校长张众参加项目阶段性总结活动。 2025年6月，上海农商银行与上海理工大学签署早期科技成果转化"捐赠+"合作方案，共建成果转化赋能 生态圈。合作以来，双方聚焦医学前沿与临床需求，从103个候选项目中遴选出10个优秀项目，涵盖医 学影像与智能诊断、AI辅助诊疗、康复与神经工程、生物医药、高端医疗设备五大方向，突出体现 了"医工交叉、智能驱动、国产替代"的转化导向。针对这10个项目，上海农商银行将依托"捐赠+"合作 方案提供早 ...

Core Insights - The Nanjing Drum Tower Hospital has launched a Clinical Medicine Research Institute aimed at addressing public health needs through original research and rapid results transformation [1][2] Group 1: Platform Development - The Clinical Medicine Research Institute is a foundational platform for supporting high-quality development in the hospital, focusing on original research based on clinical needs and establishing a closed-loop system for problem-solving and results application [1][2] - The research institute includes various facilities such as a talent apartment, animal testing center, clinical research center, and medical collaborative transformation center, providing essential hardware support for disease diagnosis and treatment [2] Group 2: Research Focus and Achievements - The institute has laid out specialized research areas including metabolism, neurology, cardiovascular health, and reproductive health, with a strong emphasis on returning research outcomes to patient care [3] - Notable achievements include a project on stem cell therapy for premature ovarian failure, which has been implemented in Hainan, and an innovative tumor vaccine developed from newly identified clinical targets, providing new treatment options for solid tumor patients [3] Group 3: Future Aspirations - The institute aims to integrate more resources with the support of provincial and municipal policies to enhance public health and contribute significantly to the local biomedicine industry [3]

Group 1 - The Fourth Zhong Nanshan Youth Science and Technology Innovation Award was held in Guangzhou, recognizing ten outstanding young scientists in the fields of medicine and life sciences [1] - The award aims to promote the spirit of scientific innovation and encourage young scientists to contribute to national development and modernization [2][5] - The event included the announcement of the award winners, the establishment of an academic cooperation platform, and the launch of various activities such as the "Technology Light" youth lecture series and academic seminars [7][9] Group 2 - Xu Xiao emphasized the importance of the award in cultivating youth role models in science and technology, aligning with the call for building a strong technological nation [2] - Zhong Nanshan encouraged young scientists to focus their research on national needs and to embrace interdisciplinary collaboration, particularly in areas like big data and artificial intelligence [5] - The event was attended by nearly 300 participants, including representatives from various scientific and educational organizations, highlighting the collaborative effort in promoting youth innovation [9]

Core Viewpoint - The article emphasizes the integration of clinical needs with technological innovation in the medical field, highlighting Shanghai Ninth People's Hospital's (Shanghai Jiu Hospital) unique "clinical-driven" model for medical technology transformation [5][6]. Group 1: Innovation and Technology - Shanghai Jiu Hospital has established itself as a leader in medical technology transformation, consistently ranking high in China's hospital innovation transformation rankings [5]. - The hospital has developed several innovative medical devices, including the "Honghu" surgical robot, which has been exported to 26 countries and has completed over 3,000 surgeries globally [6][7]. - The hospital's approach involves a collaborative model where clinical insights from doctors are combined with engineering capabilities to create innovative solutions [6]. Group 2: Ecosystem for Transformation - Shanghai Jiu Hospital has built a comprehensive ecosystem covering the entire process from idea generation to research and development, validation, and transformation, aimed at lowering barriers for inventors [7][8]. - The hospital has established a dedicated office for technology transfer, which serves as a crucial link between medical innovation and its application in practice [8]. - A professional team has been formed to provide full-process support for technology transfer, including roles such as technology brokers and patent agents [8]. Group 3: Policy and Incentives - The hospital has implemented a robust system of 45 institutional documents to ensure compliance in the management of intellectual property and technology transfer processes [9]. - A revenue-sharing mechanism has been established, allocating 80% of net income from technology transfer to reward the technical teams involved, thereby encouraging participation in innovation [9]. - The hospital provides a "Knowledge Property Transformation Pocket Manual" to all medical and research staff, serving as a guide for connecting laboratory innovations with market opportunities [9].

Core Viewpoint - The event aims to promote the integration of medical and engineering fields, focusing on technological innovation and the deep integration of the medical industry, while providing a platform for collaboration among experts, investors, and innovative enterprises [1]. Event Details - The Future Industry Innovation Seminar on Medical-Engineering Cross-Integration will be held on December 23, 2025, at Tsinghua Science Park Medical-Engineering Cross-Innovation Center [1]. - The event is part of the "2025 Tsinghua Star Annual DEMO DAY" series, gathering clinical experts, investment institutions, industry associations, and innovative companies [1]. - The agenda includes registration, opening remarks, mentor awarding, platform introduction, keynote speeches, and networking opportunities [2][3]. Keynote Topics - Topic 1: "Promoting Results Transformation and Iteration from Technology to Artificial Joints in Total Knee Replacement" presented by a professor from Tsinghua University [3]. - Topic 2: "Exploration of Trends in China's Biopharmaceutical Industry and Investment Development" by the General Manager of a medical fund [3]. - Topic 3: "Medical-Engineering Cross-Validation Platform Supporting Medical Technology Results Transformation" by the head of a validation center [3]. - Topic 4: "Global Medical Technology Innovation Ecosystem" by the editor-in-chief of a medical technology media matrix [3]. Organizing Entities - The event is organized by Tsinghua Holdings, Tsinghua Star, and Tsinghua Science Park Medical-Engineering Cross-Innovation Center, with support from various academic and industry organizations [2].

Core Viewpoint - The seminar aims to promote the integration of medical and engineering fields, focusing on technological innovation and the deep integration of the medical industry, while providing a platform for collaboration among clinical experts, investment institutions, industry associations, and innovative enterprises [2]. Group 1: Event Overview - The seminar will take place on December 23, 2025, at the Tsinghua Technology Park Medical-Engineering Innovation Center [1][3]. - It is part of the "2025 Yidian Star Annual DEMO DAY" series, emphasizing cutting-edge areas in medical-engineering intersections [2]. Group 2: Organizational Structure - The event is guided by Tsinghua Holdings and organized by Yidian Star and the Tsinghua Technology Park Medical-Engineering Innovation Center, with joint sponsorship from several prestigious institutions including Tsinghua University [3]. Group 3: Agenda Highlights - The agenda includes a series of presentations on topics such as the integration of medical engineering and the trends in the biopharmaceutical industry, featuring experts from Tsinghua University and investment firms [5]. - Key topics include the promotion of results transformation in knee replacement surgery, investment trends in China's biopharmaceutical industry, and the role of validation platforms in medical technology [5]. Group 4: Registration Information - Registration for the event is required and can be completed through a provided link or QR code [6]. Group 5: Notable Companies and Institutions - The event will feature notable medical technology companies such as Medtronic, Boston Scientific, and others, highlighting the innovation landscape in the medical technology sector [7].

Core Insights - The 20th anniversary of the merger between Shanghai Jiao Tong University and Shanghai Second Medical University highlights the successful integration of resources and disciplines, leading to a model of excellence in medical education and research known as the "Jiao Medical Model" [1][10][12] Group 1: Merger and Development - The merger in 2005, supported by the Ministry of Education and Shanghai government, has evolved from a "physical superposition" to a "chemical fusion," achieving a win-win effect [1][10] - The "Jiao Medical Model" has been recognized as a successful exploration of building high-level medical schools within comprehensive universities in China [1][12] Group 2: Research and Innovation - The medical engineering cross-disciplinary research fund has invested a total of 674 million yuan, supporting over 2,000 projects and providing crucial funding for more than 1,900 researchers [3] - The number of national natural science fund projects has ranked first among medical schools in China for 16 consecutive years, with funding increasing from 69 million yuan in 2005 to 1.259 billion yuan in 2024 [5][9] Group 3: Talent Development - Over the past 20 years, the medical school has produced 4 academicians from the Chinese Academy of Sciences and 5 from the Chinese Academy of Engineering, with a 13-fold increase in national high-level talent selections [7] - The number of undergraduate admissions has grown from 710 to 1,045, and graduate admissions from 670 to 2,300, reflecting the institution's rising academic standards [7] Group 4: Future Directions - The new Pudong campus aims to further integrate medical engineering, medical theory, and medical humanities into the development of the college [13] - The leadership is focused on resource sharing and complementary advantages to enhance the university's role in Shanghai's global innovation center [13]

Core Viewpoint - The article emphasizes the establishment of a communication platform by Suyu MedTech that connects innovators, clinicians, business managers, investors, and researchers to facilitate resource sharing and project advancement, aiming for a systematic and sustainable approach by 2026 [2]. Group 1: Conference System - The conference system will focus on "medical-engineering intersection, real-world innovation, clinical value, and industry frontiers," aiming to build a top-level communication framework within the industry [3]. - The planned conferences for 2026 include: - March 19, 2026: Third Medical Device R&D Forum in Beijing - April 24, 2026: Fourth Medical Device R&D Forum in Beijing (tentative) - May 28, 2026: Second Global Aesthetic Technology Conference in Shenzhen (tentative) - June 11, 2026: Second Global Ophthalmology Conference in Beijing - July 9, 2026: Third Global Biopharmaceutical Conference in Beijing [4][5]. Group 2: Weekly Closed-Door Activities - Starting in 2026, a weekly closed-door activity system will be established to facilitate more focused and practical exchanges [7]. - Expected themes for these activities include: 1. Global enterprise landscape and industry chain observation 2. Technological innovation in clinical scenarios 3. Market access, pricing, and insurance 4. Branding and communication strategies [8]. Group 3: Lab to Market Training Series - A systematic training course will be developed for engineers, researchers, clinicians, and entrepreneurs, focusing on the transition from lab to market [10]. - The article invites feedback from industry professionals regarding their roles, product lines of interest, industry pain points, and desired event types to tailor the activities effectively [10][12].

Core Insights - The article emphasizes the importance of innovation in the medical technology sector, particularly in China, and aims to connect clinical practices, capital, channels, and regulations to drive high-quality development in the industry [1]. Event Overview - The event is designed for future leaders in healthcare, focusing on "thought zeroing" and "ecological linking" to foster collaboration and innovation in the medical field [3]. - The event will feature a series of workshops and discussions aimed at addressing key challenges in the medical technology industry, including the transition from laboratory to production and the identification of valuable enterprises by capital [12][13]. Workshop Highlights - Workshop 1 will focus on overcoming the "valley of death" in transitioning from laboratory innovations to production lines, featuring experts from various medical and investment backgrounds [12]. - Workshop 2 will address how innovative technologies can effectively solve clinical pain points and deliver value, with insights from medical professionals and investment experts [12]. - Workshop 3 will explore how capital can identify and support genuinely valuable companies in the new economic cycle, featuring discussions led by experienced investors and industry leaders [12]. Keynote Sessions - The keynote session will include discussions on the restructuring of medical interests and the thought processes necessary for medical enterprises to thrive in a changing landscape, led by prominent figures in the healthcare and finance sectors [13]. - Another session will provide an analysis of the macroeconomic and financial landscape in China, offering insights into how these factors impact the medical technology industry [13].

Group 1 - The core viewpoint of the article highlights the upcoming clinical use of a domestically developed fetal magnetocardiography device in Shanghai, which provides new evidence for early screening of complex congenital heart diseases, filling a technological gap in the domestic market [1] - The fetal magnetocardiography device is capable of non-invasive and contactless precise capture of fetal heart signals that traditional devices struggle to identify, representing a significant breakthrough in fetal heart health assessment [3] Group 2 - This innovative achievement has realized a complete innovation chain from technology research and development to industrial transformation, benefiting from the interdisciplinary medical-engineering collaboration established over the past twenty years between Shanghai Jiao Tong University and Shanghai Second Medical University [4] - The universities have implemented an "医+X" innovation model that breaks down traditional disciplinary barriers and supports the cultivation of interdisciplinary talents, alongside establishing a medical-engineering cross-research fund with a cumulative investment of approximately 674 million yuan, providing project funding to multiple medical fields [4]